Proactive Investors
16 Oct 2026, 07:37 UTC · 1h ago
Man Group shares rise 4% as inflows beat forecasts; Peel Hunt reiterates 'buy'
Impact · against what's priced in
Man Group shares are reacting to a significant beat in net inflows and a decadal high in assets eligible for performance fees, which suggests a stronger H2 2026 revenue profile than expected. International Biotechnology Trust's consistent benchmark outperformance is noted, though it provides less immediate catalyst potential than the Man Group data.
- EMG+0.70
No priced-in read yet
- In context
Net inflows of $10.1 billion crushed the $3.8 billion consensus, while $53 billion in assets hitting high-water marks signals a substantial spike in performance fees not previously forecasted.
Read from the article alone
